« FDA Approvals - Merck is on the mend (CNN Money) In the dark | Main | FDA Approvals - New Clinical Data for PROSTASCINT(R) and QUADRAMET(R) in Prostate Cancer »

Pro-Pharmaceuticals Meeting Scheduled with the FDA (Business Wire via Yahoo!


Pro-Pharmaceuticals Meeting Scheduled with the FDA (Business Wire via Yahoo! Finance)
NEWTON, Mass.----Pro-Pharmaceuticals, Inc. , a developer of novel carbohydrate compounds, today announced that a meeting with the U.S. Food & Drug Administration is scheduled for April 11th to discuss data and plans for submitting a New Drug Application , under Section 505 for DAVANAT to be co-administered with 5-Fluorouracil to treat cancer patients. 5-FU is one of the most widely used ...

Caremark Mails Supplemental Disclosures; Shareholder Vote to Be Held on March 16 (Business Wire via Yahoo! Finance)
NASHVILLE, Tenn.----Caremark Rx, Inc. today mailed supplemental disclosures regarding shareholder appraisal rights and the structure of fees to its financial advisors in connection with Caremark's planned merger with CVS .

Sparta Systems Announces Software For Electronic Submission Of Medical Device Reports To Food And Drug Administration ... (PharmaceuticalOnline)
Sparta Systems, Inc. (Sparta), the maker of TrackWise, and the market leader in enterprise quality and compliance process management software, today announced that it has released the Beta version of the TrackWise eMDR Submission Manager software.
 

©2006 FDA-News.com. All rights reserved.